Cannabis Laws in United Kingdom

The United Kingdom legalized medical cannabis in November 2018, prompted by high-profile cases of children with severe epilepsy whose families campaigned publicly for access to cannabis-based treatments. The change reclassified cannabis-based products for medicinal use (CBPMs) from Schedule 1 to Schedule 2, allowing specialist doctors to prescribe them. However, the reality of medical cannabis access in the UK has been marked by a stark divide: the National Health Service (NHS) has issued very few prescriptions, while a growing network of private cannabis clinics has emerged to fill the gap, serving tens of thousands of patients.

Recreational cannabis remains a Class B controlled substance in the UK, with possession carrying a maximum penalty of 5 years imprisonment, though police increasingly use discretionary warnings or cautions for small amounts. The UK is paradoxically one of the world's largest exporters of legal cannabis, with British Sugar's subsidiary growing cannabis under government license for pharmaceutical export. The CBD market has flourished since the Food Standards Agency (FSA) established a novel foods regulatory pathway, and the UK CBD market is one of the largest in Europe. Despite growing public support for reform, there is limited political appetite for recreational legalization among major parties.